Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 48th Annual Meeting of the Infectious Diseases Society of America

Closing in on Meningococcal Disease

Vancouver, British Columbia / October 21-24, 2010

Vancouver - Quadrivalent conjugated vaccines have proven highly effective against 4 serotypes of invasive meningococcal disease, including the virulent type C. Evidence indicates that booster vaccination in older individuals has the...

PRIORITY PRESS - 48th Annual Meeting of the Infectious Diseases Society of America

Pneumococcal Vaccination: A North American Perspective

Vancouver, British Columbia / October 21-24, 2010

Universal vaccination programs for children using the 7-valent conjugated pneumococcal vaccine PCV7, initiated in British Columbia and Alberta in 2002 and in the rest of Canada in 2005, have resulted in a decline in disease burden and a...

PRIORITY PRESS - 17th International Pathogenic Neisseria Conference

Meningococcal Disease: Quadrivalent Vaccine Efficacy and Emerging Vaccine Against Serogroup B Disease

Banff, Alberta / September 11-16, 2010

Invasive meningococcal disease is rare but potentially fatal and is often associated with significant clinical sequelae. Distribution of the five major serogroups which cause invasive meningococcal disease—A, B, C, W-135 and...

RESOURCE LINE

VACCINE

July-September 2010

Quadrivalent HPV vaccine: strong, sustained protection against low-grade lesions Dillner J and the FUTURE I/II Study Group. Four-year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low-grade cervical, vulvar, and...

PRIORITY PRESS - 26th International Papillomavirus Conference

Reducing the Burden of HPV-related Disease in Men and Women

Montreal, Quebec / July 3-8, 2010

According to Dr. Suzanne Garland, Director, Microbiological Research, Royal Women’s Hospital, Melbourne, Australia, genital warts (GWs) are the most common condition seen in sexual health services in the country. Multiple visits are...

RESOURCE LINE

VACCINE

April-June 2010

NACI recommendations for herpes zoster vaccination Canada Communicable Disease Report (CCDR). Online publication January 2010;36(ACS-1):1-19. The National Advisory Committee on Immunization (NACI) has now recommended the herpes zoster...

PRIORITY PRESS - 28th Annual Meeting of the European Society of Pediatric Infectious Diseases (ESPID)

Countering Increased Vulnerability to Meningococcal Disease

Nice, France / May 4-8, 2010

Nice - The incidence of invasive meningococcal disease has dropped dramatically in Canada and most Western countries as a result of mass immunization campaigns in the 1990s. However, declining immunological protection is occurring as...

PRIORITY PRESS - 28th Annual Meeting of the European Society of Pediatric Infectious Diseases (ESPID)

Broadening Protection Against Pneumococcal Disease with Multivalent Vaccines

Nice, France / May 4-8, 2010

Nice - Streptococcus pneumoniae remains the leading cause of vaccine-preventable death worldwide, with an annual mortality of up to 1 million in young children and up to 1.6 million including the elderly. Children under 5 years of age are...

PRIORITY PRESS - 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

Broadening Vaccine Serotype Coverage Against Emerging Antibiotic Resistance

Vienna, Austria / April 10-13, 2010

Vienna - The burden of pneumococcal diseases caused by Streptococcus pneumoniae is particularly high among young children and those aged over 65 years. In 2000, the 7-valent conjugate pneumococcal vaccine (PCV7) was approved for use in...

PAGE 9 OF 15   1 2 3 4 5 6 7 8 9 10 ...